Permethrin Foam 4% + Permethrin Foam 5% + Vehicle Foam
Phase 2Completed 0 watching 0 views this week⚡ Active
49
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Scabies
Conditions
Scabies
Trial Timeline
Apr 1, 2014 → Dec 1, 2014
NCT ID
NCT02094716About Permethrin Foam 4% + Permethrin Foam 5% + Vehicle Foam
Permethrin Foam 4% + Permethrin Foam 5% + Vehicle Foam is a phase 2 stage product being developed by Viatris for Scabies. The current trial status is completed. This product is registered under clinical trial identifier NCT02094716. Target conditions include Scabies.
Hype Score Breakdown
Clinical
17
Activity
12
Company
7
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02094716 | Phase 2 | Completed |
Competing Products
3 competing products in Scabies
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Spinosad Topical | Inotiv | Approved | 77 |
| Permethrin | Dr. Reddy's Laboratories | Phase 3 | 74 |
| Permethrin Cream, 5% + Elimite | Mayne Pharma Group | Phase 3 | 69 |
Other Products from Viatris
Revefenacin + Tiotropium + Revefenacin Placebo + Tiotropium PlaceboApproved
82
PregabalinApproved
82
Imiquimod + DiclofenacApproved
82
gabapentin 600 mg + gabapentin 1200 mg + gabapentin 1800 mg + diazepam 20 mgApproved
82
Sulfamylon® For 5 % Topical Solution + Topical Antimicrobial/Antifungal MedicationsApproved
82